Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?

26 June 2020: Original Paper

Should Pre-Transplant Hemoglobin A Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?

Samantha L. Terranella ^ABDEF , Jennifer Poirier ^ACDE , Edie Y. Chan ^ADE , Martin Hertl ^ADE , Oyedolamu K. Olaitan ^ABCDEF*

DOI: 10.12659/AOT.924061

Ann Transplant 2020; 25:e924061

Table 2 Baseline recipient, donor, and operative characteristics by HbA1c level.

	HbA1c ≤7.7% (135 patients)	HbA1c >7.7% (30 patients)	p-Value
Recipient age (years)	57.9 (10.2)	56.1 (9.6)	0.40
BMI (kg/m)	29 (5.2)	30.5 (5.2)	0.13
Time on dialysis (months)	47 (39.5)	35 (29.0)	0.25
Length of stay (days)	9.3 (14) []⁶	7.2 (2.7) []⁶	0.80
Cold ischemia time (hours)	22 (9.8)	20 (10.6)	0.40
Anastomotic time (minutes)	49 (15.2)	47 (11.5)	0.70
PRA	11.8 (23.8)	17.6 (33.4)	0.90
Follow-up (months)	39.2 (14.7)	42 (16.4)	0.21
Donor age (years)	42 (17)	44 (15)	0.50
Re-transplant			0.50
Yes	13 (10%)	3 (10%)
No	122 (90%)	27 (90%)
Gender			0.80
Female	49 (36%)	9 (30%)
Male	86 (64%)	21 (70%)
Race			0.70
Black	52 (39%)	11 (36.7%)
Hispanic	38 (28%)	11 (36.7%)
White	34 (25%)	7 (23.3%)
Other	11 (8%)	1 (3.3%)
Type of diabetes			0.05
Type I	4 (3%)	6 (20%)
Type II	111 (82%)	22 (73.3%)
Unclassified	20 (15%)	2 (6.7%)
Diabetic medications			0.40
Insulin	92 (68%)	23 (77%)
OHA	21 (15%)	4 (13%)
Both	18 (13%)	3 (10%)
Type of graft			0.26
SCD	93 (69%)	16 (53%)
ECD	27 (20%)	9 (30%)
DCD	15 (11%)	5 (17%)
Donor type			0.18
Deceased donors	70 (52%)	17 (57%)
Living donors	65 (48%)	13 (43%)
Data presented as mean (standard deviation) [median] or count (percentage). PRA – Panel Reactive Antibody; OHA – Oral Hypoglycemic Agent; SCD – Standard Criteria Donor; ECD – Extended Criteria Donor; DCD – Donation after Cardiac Death.